CA
ELV icon

Capitolis Advisors’s Elevance Health ELV Stock Holding History

Capitolis Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-80,871
Closed -$37.5M – 254
2021
Q4 		$37.5M Buy
80,871
+67,083
+487% +$28.2M 0.22% 91
2021
Q3 		$5.35M Sell
13,788
-27,012
-66% -$10.3M 0.05% 228
2021
Q2 		$15.6M Sell
40,800
-37,116
-48% -$14.2M 0.18% 126
2021
Q1 		$28M Buy
77,916
+63,262
+432% +$20.3M 0.48% 49
2020
Q4 		$4.71M Buy
+14,654
New +$4.5M 0.08% 212

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Capitolis Advisors's ELV Position: Q1 2022 in Review

Capitolis Advisors sold out of Elevance Health (ELV) in Q1 2022, closing a stake of 80,871 shares — an estimated $37.5M sold.

Capitolis Advisors first reported a position in ELV in Q4 2020 and held it in 5 quarters. The position peaked at $37.5M in Q4 2021. 1,418 funds tracked by Wall St. Rank hold ELV as of Q1 2022.

  • Capitolis Advisors reported no remaining Elevance Health position as of Q1 2022 after selling out during the quarter.
  • Capitolis Advisors sold 80,871 Elevance Health shares in Q1 2022, an estimated $37.5M.
  • Capitolis Advisors first reported a position in Elevance Health in Q4 2020 and held it in 5 quarters.
  • Capitolis Advisors's Elevance Health position peaked at $37.5M in Q4 2021.
  • 1,418 funds tracked by Wall St. Rank held Elevance Health as of Q1 2022.

Based on Capitolis Advisors's 13F filing for Q1 2022, filed 12 May 2022.